Savings & Support with Lilly Support Services™ for Omvoh. Lilly Support Services can help you throughout your Omvoh treatment journey. Learn More

Omvoh is a biologic medicine. Biologic medicines are usually given by intravenous (IV) infusion or subcutaneous injection. Biologic medicines are proteins that would break down in stomach acid. That’s why Omvoh is first given as an IV infusion through a vein in the arm.

Omvoh injection is available as a 300mg/15 mL solution in a single-dose vial for intravenous infusion, and as a 100 mg/mL solution or a 200 mg/2 mL solution in a single dose prefilled pen or prefilled syringe for subcutaneous injection.

Learn how to get started on Omvoh first with IV infusions that then transition to self injections. Find dosing and maintenance for using Omvoh to treat UC or Crohn's disease.

Omvoh injection is available as a 300mg/15 mL solution in a single-dose vial for intravenous infusion, and as a 100 mg/mL solution or a 200 mg/2 mL solution in a single dose prefilled pen or prefilled syringe for subcutaneous injection.

Omvoh injection is available as a 300mg/15 mL solution in a single-dose vial for intravenous infusion, and as a 100 mg/mL solution or a 200 mg/2 mL solution in a single dose prefilled pen or prefilled syringe for subcutaneous injection.

Omvoh Together ™ is now Lilly Support Services. Lilly Support Services for Omvoh offers the support you need, when you need it. Enrolling in Lilly Support Services, a customer support program, can be a way to help you with your Omvoh treatment journey.

Oct 25, 2024 · Omvoh injection is available as a 300mg/15 mL solution in a single-dose vial for intravenous infusion, and as a 100 mg/mL solution or a 200 mg/2 mL solution in a single dose prefilled pen or prefilled syringe for subcutaneous injection.

Find Omvoh efficacy data for Ulcerative Colitis, including clinical remission and other endpoints from pivotal trials.

Most common adverse reactions associated with Omvoh (≥2% of subjects and at a higher frequency than placebo) in ulcerative colitis treatment are upper respiratory tract infections and arthralgia during the induction study (UC-1), and upper respiratory tract infections, injection site reactions, arthralgia, rash, headache, and herpes viral ...